The NanoB2A group is a multidisciplinary research team led by Prof. Laura M. Lechuga. We are physicists, engineers, chemists, and biologists working in the broad field of Nanobiotechnology. Our motivation is to develop new and pioneering nanotechnologies that promote and boost healthcare and well-being for the general society.
Our research is focused on the development of optical biosensors and their application in clinics, biomedicine, and environmental areas. We exploit Nanoplasmonics and Silicon Nanophotonics technologies to accomplish integrated biosensing systems for the label-free, real-time, and multiplexed analysis at the point of care. Our activity comprehends the entire development process of new biosensors, including design and nanofabrication, surface biofunctionalization, lab-on-a-chip integration, and the final validation in real scenarios.
NanoB2A group is established at the Catalan Institute of Nanoscience and Nanotechnology (ICN2), in Barcelona (Spain), belonging to the CERCA network of Catalan Research Institutes and integrated in BIST (Barcelona Institute of Science and Technology). The NanoB2A belongs as well to the Spanish National Research Council (CSIC) and the Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN).